title: The Global Innovation Model for Antibiotics Needs Reinvention.
abstract: The dangers presented by antibiotic resistance (ABR) have now established themselves as a global health security issue. From an international policy perspective, three key pillars have been established - responsible access, conservation, and innovation. These pillars are intrinsically linked, meaning that any attempt to address one, must take into account the implications for the other two. This article attempts to address all three of these pillars.
authors.affiliation: Executive Director at Access Campaign, Médecins Sans Frontiùres.
authors.forename: Manica
authors.initials: M
authors.lastname: Balasegaram
authors.affiliation: Senior Consulting Fellow at Chatham House, The Royal Institute of International Affairs.
authors.forename: Charles
authors.initials: C
authors.lastname: Clift
authors.affiliation: Director of the Division of Infectious Disease Control at the Norwegian Institute of Public Health, University of Oslo and an Assistant Professor at the Harvard T.H. Chan School of Public Health.
authors.forename: John-Arne
authors.initials: JA
authors.lastname: Røttingen
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D055808:Drug Discovery; D004345:Drug Industry; D004352:Drug Resistance, Microbial; D006801:Humans; D017146:Models, Organizational
chemical_list: D000900:Anti-Bacterial Agents